The global autoinjectors market is projected to grow at an annualized rate of ~10%>>

Roots Analysis has done a detailed study on Global Autoinjectors Market (3rd Edition), 2020-2030, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.
To order this 600+ page report, which features 360+ figures and 350+ tables, please visit this link
Key Market Insights 
  • Currently, several companies claim to be engaged in the development / manufacturing of various types of autoinjectors, most of which are disposable systems that use prefilled syringes as primary drug containers
  • About 90 autoinjector-based combination products have been approved for the treatment of a variety of clinical conditions; the subcutaneous route being the preferred mode of drug delivery via such devices
  • In order to gain a competitive edge in the market, many autoinjector manufacturers are focusing on the integration of advanced features into their respective products and affiliated offerings
  • Over time, more than 4,600 patents have been filed / granted related to autoinjectors and affiliated products; most of the new intellectual property is related to additional features, such as safety locks and device connectivity
  • Eminent scientists from renowned organizations and academic institutions across the world have made valuable contributions to this field, in terms of leading clinical research efforts and developing novel technologies
  • Several autoinjector developers have established strong brand positions in different geographies; the focus, in the near term, is likely to be on further enhancing device features for better disease management and improved patient compliance
  • An evaluation of 200+ marketed and pipeline products revealed that a variety of drugs / product candidates are likely to be considered for administration via autoinjectors in the near future
  • Case Study: Owing to the complexities associated with the manufacturing and assembly of autoinjector drug delivery systems, industry players are known to frequently engage the services of contract service providers
  • Currently, disposable autoinjector products for small molecule drugs dominate the market; however, in the foreseen future, the demand for reusable devices is anticipated to witness significant growth
  • Given the recent approvals and presence of multiple drug candidates in later stages of development, the market opportunity is likely to be distributed across different therapeutic areas, routes of administration and geographies
For more information, please visit
Table of Contents
1.              PREFACE
1.1.           Scope of the Report
1.2.           Research Methodology
1.3.           Chapter Outlines
2.              EXECUTIVE SUMMARY
3.              INTRODUCTION
3.1.           Chapter Overview
3.2.           Types of Drug Delivery Systems
3.3.           Drawbacks of Conventional Parenteral Delivery Systems
3.4.           Needlestick Injuries
3.4.1.        Incidence and Cost Burden
3.4.2.        Government Legislation for the Prevention of Needlestick Injuries            
3.5.           Emerging Trend of Self-Administration
3.5.1.        Rising Burden of Chronic Diseases
3.5.2.        Healthcare Cost Savings
3.5.3.        Need for Immediate Treatment in Emergency Situations
3.5.4.        Growth of Injectable Biologics Market
3.5.5.        Addressing Key User Safety Requirements 
3.6.           Types of Self- Administration Devices
3.6.1.        Prefilled Syringes
3.6.2.        Pen-Injectors
3.6.3.        Needle-Free Injectors
3.6.4.        Autoinjectors
3.6.5.        Large Volume Wearable Injectors
3.7.           Overview of Autoinjectors
3.7.1.        Components of Autoinjectors
3.7.2.        Classification of Autoinjectors      On the Basis of Mechanism of Action      On the Basis of Usability      On the Basis of Type of Dose 
3.7.3.        Manufacturing / Packaging of Autoinjectors
3.7.4.        Benefits of Autoinjectors
3.8.           Regulatory Considerations
3.8.1.        Medical Devices
3.8.2.        Drug Device Combination Products
3.9.           Future Perspectives
4.1.           Chapter Overview
4.2.           Types of Packaging
4.3.           Introduction to Primary Drug Containers
4.3.1.        Role of Primary Drug Containers
4.3.2.        Types of Primary Drug Containers      Cartridges   Components of Cartridges   Types of Cartridges  Single Chamber Cartridge  Dual Chamber Cartridge   Cartridges Available in the Market
              Syringes   Components   Types of Syringes  Based on Number of Chambers  Based on Type of Needle   Prefilled Syringe Systems Available in the Market  Glass Prefilled Syringes  Plastic Prefilled Syringes
              Vials   Components   Vials Available in the Market
4.4.           Comparison of Fabrication Materials
5.1.           Chapter Overview
5.2.           Autoinjectors: List of Devices
5.2.1.        Analysis by Usability 
5.2.2.        Analysis by Type of Primary Container
5.3.           Autoinjectors: List of Additional Parameters of Devices
5.3.1.        Analysis by Volume of Container
5.3.2.        Analysis by Type of Dose
5.3.3.        Analysis by Route of Administration
5.3.4.        Analysis by Actuation Mechanism
5.3.5.        Analysis by Type of Feedback Mechanism
5.4.           Autoinjectors: List of Developers
5.4.1.        Analysis by Year of Establishment
5.4.2.        Analysis by Company Size
5.4.3.        Analysis by Geographical Location of Headquarters
6.1.           Chapter Overview
6.2.           Methodology
6.3.           Assumptions and Key Parameters
6.4.           Product Competitiveness Analysis
6.4.1.        Disposable Autoinjectors
6.4.2.        Reusable Autoinjectors
7.1            Chapter Overview
7.2.           Scope and Methodology
7.3.           Brand Positioning Matrix: Antares Pharma 
7.4.           Brand Positioning Matrix: BD
7.5.           Brand Positioning Matrix: DALI Medical Devices 
7.6.           Brand Positioning Matrix: Elcam Drug Delivery Devices 
7.7.           Brand Positioning Matrix: Oval Medical Technologies 
7.8            Brand Positioning Matrix: Owen Mumford 
7.9.           Brand Positioning Matrix: SHL Medical 
7.10          Brand Positioning Matrix: Union Medico
7.11.         Brand Positioning Matrix: Ypsomed 
8.              PATENT ANALYSIS
8.1.           Chapter Overview
8.2.           Scope and Methodology
8.3.           Autoinjectors: Patent Analysis
8.3.1.        Analysis by Application Year
8.3.2.        Analysis by Issuing Authority
8.3.3.        Analysis by CPC Symbols 
8.4.           Emerging Areas
8.5.           Leading Players Based on Number of Patents
8.6.           Autoinjectors: Patent Benchmarking Analysis
8.6.1.        Analysis by Patent Characteristics
8.6.2.        Analysis by Geography
8.7.           Autoinjectors: Patent Valuation Analysis
9.1.           Chapter Overview
9.2.           Autoinjector Combination Products: List of Approved Drugs
9.2.1.        Analysis by Initial Year of Approval
9.2.2.        Analysis by Usability
9.2.3.        Analysis by Route of Administration
9.2.4.        Analysis by Primary Drug Container
9.3.           Approved Autoinjector Combination Products: List of Additional Parameters
9.3.1.        Analysis by Type of Molecule
9.3.2.        Analysis by Dose Strength
9.3.3.        Analysis by Therapeutic Indication
9.3.4.        Analysis by Other Packaging Formats of Marketed Drugs
9.4.           Autoinjector Combination Products: List of Pipeline Drugs
9.4.1.        Analysis by Phase of Development
9.5.           Pipeline Autoinjector Combination Products: List of Additional Parameters 
9.5.1.        Analysis by Route of Administration
9.5.2.        Analysis by Type of Molecule 
9.5.3.        Analysis by Therapeutic Indication
9.5.4.        Grid Analysis: Distribution by Therapeutic Indication, Phase of Development and Route of Administration
9.6.           Autoinjector Combination Products: List of Developers
9.6.1.        Analysis by Year of Establishment
9.6.2.        Analysis by Company Size
9.6.3.        Analysis by Location of Headquarters
10.1.         Chapter Overview
10.2.         Marketed / Pipeline Drugs Being Evaluated with Autoinjectors
10.3.         Case Study I: Anaphylaxis
10.3.1.       Overview and Epidemiology
10.3.2.       Adrenaline: Mechanism of Action 
10.3.3.       History of Development
10.3.4.       Marketed Adrenaline / Epinephrine Autoinjectors    Adrenaclick    Allerject / Auvi-Q (Formerly called e-cue)    Anapen    Emerade    EpiPen / EpiPen Jr    Jext    EpiPen / EpiPen Jr
10.3.5.       Adrenaline / Epinephrine Autoinjectors Under Development    EpiQ    ANDIPen    MiniEpi    Zeneo Adrenaline
10.3.6.       Other Dosage Forms
10.3.7.       Historical Sales of Approved Drugs / Autoinjectors 
10.4.         Case Study II: Multiple Sclerosis
10.4.1.       Overview and Epidemiology
10.4.2.       Interferon β-1a 
10.4.3.       Interferon β-1b
10.4.4.       Interferons: Mechanism of Action
10.4.5.       History of Development
10.4.6.       Interferon β-1a Autoinjectors    Avonex Pen    PLEGRIDY Pen    Rebif Rebidose    RebiSmart    Rebiject II    ReciGen Physioject
10.4.7.       Interferon β-1b Autoinjectors    BETACONNECT    BETAJECT Comfort / Betacomfort    Betaject Lite    ExtaviJect 30G / ExtaviPro 30G
10.4.8.       Other Marketed Autoinjectors    Cinnomer40 Physioject    CSYNC Autoinjector    WhisperJECT    Remurel Autoxon
10.4.9.       Other Dosage Forms
10.4.10.     Historical Sales of Approved Drugs / Autoinjectors  Interferon β-1a  Interferon β-1b
10.5.         Case Study III: Migraine
10.5.1.       Overview and Epidemiology
10.5.2.       Sumatriptan Succinate: Mechanism of Action
10.5.3.       History of Development
10.5.4.       Marketed Autoinjectors    ALSUMA    IMITREX STATdose Pen    Zembrace SymTouch    Aimovig SureClick Autoinjector    Emgality Prefilled Pen
10.5.5.       Other Dosage Forms
10.5.6.       Historical Sales of Approved Drugs / Autoinjectors
10.6.         Case Study IV: Rheumatoid Arthritis
10.6.1.       Overview and Epidemiology
10.6.2.       History of Development
10.6.3.       Marketed Autoinjectors for Rheumatoid Arthritis    Actemra    CIMZIA AutoClicks Prefilled Pen    Enbrel SureClick    Hulio Prefilled Pen    HUMIRA Pen    ORENCIA ClickJect    OTREXUP    Rasuvo Autoinjector    SIMPONI SmartJect Autoinjector  KEVZARA Prefilled Pen  IMRALDI Prefilled Pen
10.6.4.       Historical Sales of Approved Drugs / Autoinjectors
11.1.         Chapter Overview
11.2.         Methodology and Key Parameters
11.3.         Marketed Drug Candidates for Delivery via Autoinjectors
11.3.1.       Most Likely Drug Candidates 
11.3.2.       Likely Drug Candidates 
11.3.3.       Less Likely Drug Candidates 
11.3.4.       Unlikely Drug Candidates 
11.4.         Clinical Drug Candidates for Delivery via Autoinjectors
11.4.1.       Most Likely Drug Candidates 
11.4.2.       Likely Drug Candidates 
11.4.3.       Less Likely Drug Candidates 
11.4.4.       Unlikely Drug Candidates 
12.            KEY PLAYERS
12.1.         Chapter Overview
12.2.         Antares Pharma
12.2.1.       Company Overview
12.2.2.       Financial Information
12.2.3.       Product Portfolio    Autoinjectors: Product Details Vibex QuickShot BigShot
12.2.4.       Collaborators    Teva Pharmaceutical    Ferring Pharmaceuticals    AMAG Pharmaceuticals    JCR Pharmaceuticals    Pfizer    Idorsia Pharmaceuticals
12.2.5.       Recent Developments and Future Outlook
12.3          Consort Medical (Previously Bespak)
12.3.1.       Company Overview
12.3.2.       Financial Information
12.3.3.       Technology Overview
12.3.4.       Product Portfolio    Autoinjectors: Product Details Syrina OTS Autoinjector Viscala Autoinjector
12.3.5.       Collaborators    Aesica Pharmaceuticals    Undisclosed Global Biopharmaceutical Company    Regeneron Pharmaceuticals
12.3.6.       Recent Developments and Future Outlook
12.4.         DALI Medical Devices
12.4.1.       Company Overview
12.4.2.       Product Portfolio    Autoinjectors: Product Details SAN-L SAN-P SAN-DV SAN-DV Pro SAN-Light
12.4.3.       Collaborators    Elcam Drug Delivery Devices
12.4.4.       Recent Developments and Future Outlook
12.5.         Elcam Medical (E3D Elcam Drug Delivery Devices)
12.5.1.       Company Overview
12.5.2.       Product Portfolio    Autoinjectors: Product Details Flexi-Q Disposable Autoinjectors      Flexi-Q PFS      Flexi-Q HV      Flexi -Q DV Flexi-Q Reusable Autoinjectors      Flexi-Q mMU      Flexi-Q eMU-C / P      Flexi-Q EAI
12.5.3.       Comparison of Elcam Medical Autoinjectors
12.5.4.       Collaborators    DALI Medical Devices
12.5.5.       Recent Developments and Future Outlook
12.6.         Jiangsu Delfu Medical Devices
12.6.1.       Company Overview
12.6.2.       Financial Information
12.6.3.       Product Portfolio    Autoinjectors: Overview and Specifications Components of Delfu Autoinjectors Applications of Delfu Autoinjectors Features of Delfu Autoinjectors Advantages of Delfu Autoinjectors Specifications of Delfu Autoinjectors    Autoinjectors: Product Details YZ-II 3mL Cartridge Digital Dose Setting GF Autoinjector DZ-IA 3 mL Cartridge Needle Hidden Vaccination Autoinjector DZ-IA Auto Injector Pen Intravitreal Anti-VEGF Injections Electric Insulin Pens YZ-III Standard 3 mL Cartridge Reusable Electronic Auto Injector Pen YZ-III 0.001mL Dose Increments Fully Automated Reusable Injectors YZ-III 0.001 mL Dose Accuracy Auto Injector Pen YZ-II 3mL* 1u Auto Injector Pen YZ-V 3 mL Cartridge Replaceable Variable-dose Classic Auto Injector Pen YZ-III Automatic Reusable Insulin Injection Pen
12.6.4.       Recent Developments and Future Outlook
12.7.         Oval Medical Technologies
12.7.1.       Company Overview
12.7.2.       Product Portfolio    Autoinjectors: Product Details  ArQ  ArQ - Bios  ArQ - Tempo  ArQ - Vita 
12.7.3.       Collaborators    SOLIZE
12.7.4.       Recent Developments and Future Outlook
12.8.         Owen Mumford
12.8.1.       Company Overview
12.8.2.       Product Portfolio    Autoinjectors: Product Details Autoject Micro Autoject 2 Autoject Mini Autoject Visco UniSafe Auto-injector UniSafe Connected Auto-injector
12.8.3.       Collaborators    Nipro    Sanofi Aventis
12.8.4.       Recent Developments and Future Outlook
12.9.         SHL Group
12.9.1.       Company Overview
12.9.2.       Product Portfolio    Two-Step Disposable Autoinjectors: Product Details  Amber (Pushclick Technology) Molly Molly RNS Molly 2.25 Rotaject Bertha DAI 2 Maggie Comparison of SHL Two-Step Autoinjectors    Three-Step Disposable Autoinjectors: Product Details DAI SDI-MIX+NIT (Needle Isolation Technology and Twist and Mix Mechanism) VSDI+NIT Comparison of SHL Three-Step Autoinjectors    PPI Injector (Rotaject Pressure Release Technology)
12.9.4.       Collaborators    Schreiner MediPharm    QuiO
12.9.5.       Recent Developments and Future Outlook
12.10.        Union Medico
12.10.1.     Company Overview
12.10.2.     Technology Overview
12.10.3.     Product Portfolio  Autoinjectors: Product Details  45˚ Autoinjector  45˚/ S Autoinjector  45˚/ M Autoinjector  45˚/ R Autoinjector  Comparison of 45˚ Autoinjectors  90˚Autoinjector  90˚/ S Autoinjector  90˚/ M Autoinjector  90˚/ XL Autoinjector      SuperGrip Autoinjector      Exclusive Autoinjector      Comparison of 90˚ Autoinjectors
12.10.4.     Recent Developments and Future Outlook
12.11.        Ypsomed
12.11.1.     Company Overview
12.11.2.     Financial Information

You may also like


No comments yet... Be the first to leave a reply! Login here

0 Karma
1329 Posts

Made with by Mamby